Dear Colleagues,
One month ago, we held another highly successful annual meeting. Attendance has continued to grow each year, with 1,334 participants this year. Many thanks to our co-chairs, Anshu Gupta and Marie‑Eve Robinson, and to the entire Program Committee for creating such an engaging and impactful experience, not to mention their rousing rendition of “Ped Endos Meet Tonight.” It was especially exciting to see so many trainees in attendance, including 342 fellows, residents, and students.
At the meeting, Paul Graham Fisher, MD, Associate Editor of The Journal of Pediatrics and Professor at Stanford University, delivered a thought‑provoking talk on publication ethics. As he summarized in an interview with our PES media crew afterward: “Pay attention to increasing ethical problems, understand the source, and recognize that there’s a lot of bad stuff out there.” In this age of misinformation, it is critical to recognize the flaws that can exist in published scientific literature, not to mention how AI can be used to manipulate data. Just this week, NBC News reported that “a network of fake academic journals masquerading as legitimate publications has published more than a hundred AI‑generated papers in recent months, in some cases using the names of real professors at top universities without their knowledge.” Please take care to critically assess everything you read.
As my term comes to a close, I want to thank you all for the privilege of representing you as PES President this past year. I have passed the gavel to Tandy Aye, and I have no doubt she will do an outstanding job.
Finally, I want to acknowledge the hard work you do every day. Please keep fighting the good fight. As Dr. Seuss wrote in The Lorax, “Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not.”
Laurie E. Cohen, MD
Past President, PES Board of Directors
2026 Annual Meeting
Thank you to everyone who helped make the 2026 Annual Meeting a success! With more than 1,300 attendees, this year’s meeting brought together the pediatric endocrinology community for an inspiring week of education, collaboration, and connection.
We’ve also uploaded photos from the meeting to the website, be sure to take a look and relive some of the highlights!
Mission Alliance Partner (MAP) Spotlight has been updated!
This enhanced platform gives our Mission Alliance Partners the opportunity to connect virtually with our members by sharing:
- Information about their company
- Product showcases and theater presentations, including newly approved products, new perspectives on existing products, and updated clinical information
- Educational sessions, such as symposium-style presentations on rare conditions and related clinical trials
- Poster presentations and resources related to current or emerging products, including guidance on product use, administration, and more
Learn more:
PES 2026 Mission Alliance Partners Spotlight - Pediatric Endocrine Society
New! PES Prader-Willi Syndrome Special Interest Group Call for Interest!
Co-Chairs: Diane Stafford and Parisa Salehi
Board Liaison: Lisa Topor
Aims: The PES PWS SIG will help all PES members to improve their clinical care of patients with PWS through increased education, collaboration and resource development. This will include efforts focused on clinical research, optimization of standards of care, and education for patients, families, and providers. The PES PWS SIG aims promote partnerships and collaboration between multidisciplinary clinical teams, individual experts, and general providers.
Learn more and sign up here: https://pes.memberclicks.net/special-interest-group--sig--sign-up-form
PCOS has a New Name: Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 170 million women worldwide.
The new name came from the largest global engagement in a name change process with 22,000 survey responses and multiple workshops including women with lived experience and health professionals, alongside 56 patient organizations and societies across the world, including PES.
For too long, PCOS reduced a complex, long term hormonal or endocrine disorder to a misunderstanding about ‘cysts’ and a focus on ovaries. This contributed to missed diagnoses and inadequate treatment.
PMOS will raise awareness, improve diagnosis and care for 1 in 8 women affected globally.
Resources in multiple languages are available: https://bit.ly/3V85nPJ
News from the D&T
Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age
The statement on iodinated contrast media and thyroid monitoring has been published in the Pediatrics May issue. The publication can now be found online here: Thyroid Monitoring After Intravascular Iodinated Contrast Media in Infants and Children Through 3 Years of Age | Pediatrics | American Academy of Pediatrics
New Meds and Tech Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D)
Online Education
PES takes pride in providing diverse online educational opportunities for our members. Our offerings include the PES SIG State of the Art Series webinars, the Quarterly Education Committee-sponsored webinar series, and the Industry Sponsored Symposia Series, all available year-round. These educational resources are among the exclusive benefits of PES membership.
Check out our education calendar for more details and links to register/access: Events for June 2026 – Pediatric Endocrine Society
SAVE THE DATE
June 2 I 12:00 - 1:00 PM ET
Calling all medical students! PES SEED Webinar: Turner syndrome/Klinefelter syndrome
---
June 4 I 5:00 - 6:00 PM ET
PES Thyroid SIG Webinar, Pediatric Thyroid US Series: 2. Abnormal Thyroid US.
---
June 9 I 6:15 - 7:15 PM ET
PES Podcast Club: Genetic Data from Over 20,000 U.S. Children Misused for ‘Race Science’
Please join the PES Health Systems & Disparities Committee for a virtual Podcast Club. This moderated community discussion will focus on the New York Times audio article, “Genetic Data from Over 20,000 U.S. Children Misused for ‘Race Science.’ New York Times audio article · January 24, 2026
The 20-minute audio piece raises important questions about research ethics, community trust, race as a social versus biological construct, and the responsibility of scientific and medical communities to advocate for ethical data governance. Participants are encouraged to listen to the article in advance and come prepared for a thoughtful discussion with HSD colleagues across PES. The session will be facilitated by Ilene Fennoy, MD, MPH. All PES members are welcome.
---
Industry Sponsored Symposium: Rethinking Short Stature Evaluation: Recognizing Hypochondroplasia and Applying New Diagnostic Guidelines
June 30 I 6:00 - 7:00 PM ET
Sponsored by BioMarin
Description: Short stature is a common presentation in pediatric endocrinology, with many patients ultimately classified as having idiopathic or familial short stature. However, underlying genetic conditions such as hypochondroplasia may be under-recognized due to variable and often subtle clinical features. This session will review key considerations in short stature evaluation that may prompt suspicion for hypochondroplasia, with a focus on clinical recognition and diagnostic assessment. The application of new diagnostic guidelines will be discussed, highlighting opportunities to support earlier and more accurate diagnosis and inform clinical management.
Speaker(s): Andrew Dauber, MD, MMSc. Additional Faculty TBA
Learning Objectives:
- Describe key considerations in short stature evaluation, including features suggestive of hypochondroplasia
- Recognize clinical findings and growth patterns that may prompt further evaluation for hypochondroplasia
- Discuss the role of new diagnostic guidelines in supporting accurate diagnosis and clinical management
Registration link: https://biomarin.ampstream.io/2026-1
Calling all Program Directors & Division Chiefs!
As we continue enhancing engagement across PES, we wanted to share a reminder that the Communities platform is now the central location for committee/group collaboration and communication. We encourage all leaders to actively utilize the platform moving forward.
All communications with Program Directors and Division Chiefs will be via the community. We have created a quick form for you to check/update your membership record to indicate that you are a Division Chief and/or a Program Director and have access to that community.
Please visit your member record and confirm that you are flagged as a Program Director or Division Chief: https://pes.memberclicks.net/division-chief-program-director-updates
Key features of the communities include:
- Discussion boards for committee/group communication (replacing standalone listservs and individual eblasts)
- File libraries for meeting minutes and shared resources
- Event calendars where all meeting information and Zoom links will now be housed
Additional reminders:
- Access is limited to active members within each committee/group (please confirm that your member record is updated via the instructions above)
- There is also a general discussion board available to all PES members
- Community members from the prior platform have been migrated
Getting Started:
- Access the platform directly at: PES Communities Platform
- Log in using your existing PES website credentials
- On first login, you’ll be prompted to accept updated Terms & Conditions
- Please add noreply@pedsendo.org to your safe senders list
Need step-by-step guidance?
Download our helpful PDF with screenshots and detailed instructions to walk you through the new platform.
Thank you all again for your leadership, partnership, and support. This forum will make direct communication with your peers easy and immediate. We appreciate your help in building a stronger, more connected PES community.
News from the NIH: Helpful Reminders to Ensure Integrity of NIH-Supported Research When Using Artificial Intelligence
Alongside NIH-supported scientific advances and priority research areas involving AI, we have also occasionally observed challenges with the use of these tools that affect the integrity of the science we support. We are sharing some helpful reminders on the appropriate use of AI tools when applying, managing awards, and conducting the research process itself. Read more:
Fellow Spotlight: Dr. Daniela Aguilar Abisad
Meet Daniela: May Fellow Spotlight – Daniela Aguilar Abisad, MD - Pediatric Endocrine Society
Historical Tidbit: May Then and Now: This Month in Endocrine History
Submitted by Evan Graber, DO
This Month in Endocrine History
May Historical Tidbit- This Month in Endocrine History - Pediatric Endocrine Society
In Memoriam: William Valentine Tamborlane Jr.
August 25, 1946 – May 12, 2026
William V. (Bill) Tamborlane was born on August 25, 1946, in the Bronx, New York, to William and Eleanor Tamborlane. He attended Bergen Catholic High School in Oradell, New Jersey, and graduated Phi Beta Kappa in Chemistry from Georgetown University in 1968 and continued his education there through medical school and residency, completing his training as Chief Resident before being accepted into a Post-doctoral fellowship in Pediatric Endocrinology at Yale University in 1975. He and his wife, Kathleen, relocated to New Haven with their two daughters, and from the moment he arrived, Bill intended to remain at Yale for the entirety of his career — a commitment he honored fully. Moving to Madison in 1977 was a highlight of his family’s life and Bill volunteered to coach little league whenever he had time and he recruited fellow Yale faculty to play basketball at Surf Club during the summer months. Learn more: https://pedsendo.org/in-memoriam/in-memoriam-william-valentine-tamborlane-jr-august-25-1946-may-12-2026/